Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca diabetes drug combination faces delay after FDA rebuff
AstraZeneca diabetes drug combination faces delay after FDA rebuff
AstraZeneca diabetes drug combination faces delay after FDA rebuff
Submitted by
admin
on October 16, 2015 - 6:58am
Source:
Yahoo/Reuters
News Tags:
AstraZeneca
diabetes
FDA
saxagliptin
Dapagliflozin
Headline:
AstraZeneca diabetes drug combination faces delay after FDA rebuff
Do Not Allow Advertisers to Use My Personal information
